These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20379810)

  • 1. A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker.
    Flamez D; Roland I; Berton A; Kutlu B; Dufrane D; Beckers MC; De Waele E; Rooman I; Bouwens L; Clark A; Lonneux M; Jamar JF; Goldman S; Maréchal D; Goodman N; Gianello P; Van Huffel C; Salmon I; Eizirik DL
    Diabetologia; 2010 Jul; 53(7):1372-83. PubMed ID: 20379810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells.
    Burtea C; Laurent S; Crombez D; Delcambre S; Sermeus C; Millard I; Rorive S; Flamez D; Beckers MC; Salmon I; Vander Elst L; Eizirik DL; Muller RN
    Contrast Media Mol Imaging; 2015; 10(5):398-412. PubMed ID: 25930968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperplasia of pancreatic beta cells and improved glucose tolerance in mice deficient in the FXYD2 subunit of Na,K-ATPase.
    Arystarkhova E; Liu YB; Salazar C; Stanojevic V; Clifford RJ; Kaplan JH; Kidder GM; Sweadner KJ
    J Biol Chem; 2013 Mar; 288(10):7077-85. PubMed ID: 23344951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.
    Demine S; Schulte ML; Territo PR; Eizirik DL
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
    Demine S; Balhuizen A; Debaille V; Joosten L; Fereau M; Chilla SNM; Millard I; Scharfmann R; Egrise D; Goldman S; Marchetti P; Gotthardt M; Laurent S; Burtea C; Eizirik DL
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30134599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic islet and progenitor cell surface markers with cell sorting potential.
    Hald J; Galbo T; Rescan C; Radzikowski L; Sprinkel AE; Heimberg H; Ahnfelt-Rønne J; Jensen J; Scharfmann R; Gradwohl G; Kaestner KH; Stoeckert C; Jensen JN; Madsen OD
    Diabetologia; 2012 Jan; 55(1):154-65. PubMed ID: 21947380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis.
    Saunders DC; Brissova M; Phillips N; Shrestha S; Walker JT; Aramandla R; Poffenberger G; Flaherty DK; Weller KP; Pelletier J; Cooper T; Goff MT; Virostko J; Shostak A; Dean ED; Greiner DL; Shultz LD; Prasad N; Levy SE; Carnahan RH; Dai C; Sévigny J; Powers AC
    Cell Metab; 2019 Mar; 29(3):745-754.e4. PubMed ID: 30449685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells.
    Ifie E; Russell MA; Dhayal S; Leete P; Sebastiani G; Nigi L; Dotta F; Marjomäki V; Eizirik DL; Morgan NG; Richardson SJ
    Diabetologia; 2018 Nov; 61(11):2344-2355. PubMed ID: 30074059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates.
    Lindskog C; Korsgren O; Pontén F; Eriksson JW; Johansson L; Danielsson A
    J Proteomics; 2012 May; 75(9):2611-20. PubMed ID: 22465717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability.
    Jones DH; Li TY; Arystarkhova E; Barr KJ; Wetzel RK; Peng J; Markham K; Sweadner KJ; Fong GH; Kidder GM
    J Biol Chem; 2005 May; 280(19):19003-11. PubMed ID: 15755730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets.
    Lindskog C; Asplund A; Engkvist M; Uhlen M; Korsgren O; Ponten F
    Discov Med; 2010 Jun; 9(49):565-78. PubMed ID: 20587347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.
    Richardson SJ; Rodriguez-Calvo T; Gerling IC; Mathews CE; Kaddis JS; Russell MA; Zeissler M; Leete P; Krogvold L; Dahl-Jørgensen K; von Herrath M; Pugliese A; Atkinson MA; Morgan NG
    Diabetologia; 2016 Nov; 59(11):2448-2458. PubMed ID: 27506584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.
    Igoillo-Esteve M; Marselli L; Cunha DA; Ladrière L; Ortis F; Grieco FA; Dotta F; Weir GC; Marchetti P; Eizirik DL; Cnop M
    Diabetologia; 2010 Jul; 53(7):1395-405. PubMed ID: 20369226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells.
    Martinez-Pinna J; Marroqui L; Hmadcha A; Lopez-Beas J; Soriano S; Villar-Pazos S; Alonso-Magdalena P; Dos Santos RS; Quesada I; Martin F; Soria B; Gustafsson JÅ; Nadal A
    Diabetologia; 2019 Sep; 62(9):1667-1680. PubMed ID: 31250031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker.
    Altirriba J; Gasa R; Casas S; Ramírez-Bajo MJ; Ros S; Gutierrez-Dalmau A; Ruiz de Villa MC; Barbera A; Gomis R
    Diabetologia; 2010 Jul; 53(7):1406-14. PubMed ID: 20386877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased pancreatic acinar cell number in type 1 diabetes.
    Wright JJ; Saunders DC; Dai C; Poffenberger G; Cairns B; Serreze DV; Harlan DM; Bottino R; Brissova M; Powers AC
    Diabetologia; 2020 Jul; 63(7):1418-1423. PubMed ID: 32388592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Visualization of β-Cells by Targeting of GPR44.
    Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
    Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of beta cell replacement outcomes.
    Chang CA; Haque WZ; Yoshimatsu G; Balajii PS; Lawrence MC; Naziruddin B
    Panminerva Med; 2016 Mar; 58(1):59-71. PubMed ID: 26763742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.